NCT06435871View on ClinicalTrials.gov

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

NARecruitingINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
Prostate Cancer
Interventions
BEHAVIORAL

Expanded Prostate Cancer Index Composite and Decision Regret Scale

This comprehensive instrument measures urinary, sexual, and bowel symptoms in men treated for prostate cancer. It can provide a detailed view of the patient's quality of life post-treatment.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER